Abstract
High expression of LLGL2 promotes proliferation and drug resistance in ER+ breast cancer.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase Short Term Access
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
June 2019
Volume 9, Issue 6
Volume 9, Issue 6
LLGL2 Promotes Adaptation to Nutrient Stress in ER+ Breast Cancer
Jump to section
Advertisement